Will morphing boron-based inhibitors beat the β-lactamases?
The β-lactams remain the most important antibacterials, but their use is increasingly compromised by resistance, importantly by β-lactamases. Although β-lactam and non-β-lactam inhibitors forming stable acyl-enzyme complexes with nucleophilic serine β-lactamases (SBLs) are widely used, these are inc...
主要な著者: | Krajnc, A, Lang, P, Panduwawala, T, Brem, J, Schofield, C |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2019
|
類似資料
-
Bicyclic boronates as potent inhibitors of AmpC, the class C β-lactamase from escherichia coli
著者:: Lang, PA, 等
出版事項: (2020) -
Bicyclic boronate VNRX-5133 inhibits metallo- and serine-β-lactamases
著者:: Krajnc, A, 等
出版事項: (2019) -
Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition
著者:: Tooke, C, 等
出版事項: (2020) -
Synthesis and mechanistic analyses of boron-containing β-lactamase inhibitors
著者:: Krajnc, A
出版事項: (2020) -
Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from <i>Escherichia coli</i>
著者:: Pauline A. Lang, 等
出版事項: (2020-06-01)